Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Interleukin-6, a pleiotropic cytokine

Highly Access

Interleukin-6: a new therapeutic target

Josef S Smolen* and Ravinder N Maini

Arthritis Research & Therapy 2006, 8(Suppl 2):S5 doi:10.1186/ar1969

Accesses  

  • Last 30 days: 91 accesses
  • Last 365 days: 1127 accesses
  • All time: 11150 accesses